Взаимосвязь спектра безопасности нимесулида и особенностей его механизма действия, химическойструктуры и фармакокинетики
Взаимосвязь спектра безопасности нимесулида и особенностей его механизма действия, химическойструктуры и фармакокинетики
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Список литературы
1. Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rheumatology (Oxford). 1999; 38 (Suppl. 1): 4–10.
2. Rainsford KD. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161–70.
3. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174 (11): 1589–94.
4. Rainsford KD. Mode of action, uses and side-effects of anti-rheumatic drugs. In: Rainsford KD, ed. Advances in anti-rheumatic therapy. Boca Raton, FL: CRC Press 1996; 59–111.
5. Bjarnason I, Thjodleifsson B. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford). 1999; 38 (Suppl. 1): 24–32.
6. Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1994; 48: 431–54.
7. Bjarnason I. Effects of nimesulide and naproxen on the human gastrointestinal tract: a double-blind, crossover study. Rheumatology 1999; 38 (suppl. 1): 24–32.
8. Marini U, Spotti D, Magni E et al. Double-blind endoscopic study comparing the effect of nimesulide and placebo on gastric mucosa of dyspeptic patients. Drug Invest 1990; 2: 162–6.
9. Traversa G, Bianchi C, Da Cas R et al. Cohort study of hepatotoxicity associated with anti-inflammatory drugs nimesulide and other non-steroidal. BMJ 2003; 327: 18–22.
2. Rainsford KD. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161–70.
3. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 174 (11): 1589–94.
4. Rainsford KD. Mode of action, uses and side-effects of anti-rheumatic drugs. In: Rainsford KD, ed. Advances in anti-rheumatic therapy. Boca Raton, FL: CRC Press 1996; 59–111.
5. Bjarnason I, Thjodleifsson B. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford). 1999; 38 (Suppl. 1): 24–32.
6. Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1994; 48: 431–54.
7. Bjarnason I. Effects of nimesulide and naproxen on the human gastrointestinal tract: a double-blind, crossover study. Rheumatology 1999; 38 (suppl. 1): 24–32.
8. Marini U, Spotti D, Magni E et al. Double-blind endoscopic study comparing the effect of nimesulide and placebo on gastric mucosa of dyspeptic patients. Drug Invest 1990; 2: 162–6.
9. Traversa G, Bianchi C, Da Cas R et al. Cohort study of hepatotoxicity associated with anti-inflammatory drugs nimesulide and other non-steroidal. BMJ 2003; 327: 18–22.
Авторы
О.В.Воробьева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.